Becton, Dickinson and Co.
As on 18 Apr, 2026 | 01:29 IST
| Open | 155.19 |
| Previous Close | 154.82 |
| Beta | 0.57 |
| High | 159.95 |
| Low | 155.19 |
| TTM EPS See historical trend | 13.90(-0.07% YoY) |
| 52 Week High | 213.08 |
| 52 Week Low | 152.79 |
| TTM PE See historical trend | 11.40(Low PE) |
| Mkt. Cap ($ Billion) | 45.97 |
| Dividend Yield | 2.15 |
Advanced Chart
*Delayed by 20 seconds
MC Technicals
| Days | |
|---|---|
| 5 | 155.98 |
| 10 | 155.62 |
| 20 | 155.75 |
| 50 | 167.62 |
| 100 | 183.19 |
| 200 | 184.64 |
Returns
| 1 Week | 2.90% | |
| 1 Month | -1.95% | |
| 3 Months | -23.48% | |
| YTD | -18.38% | |
| 1 Year | -20.16% | |
| 3 Years | -38.15% |
Financialsin million $
Peers
| Name | Price ($) | Change% | M.Cap(Billion $) | TTM PE | TTM EPS | DY | 52 wk high/low | Technical Rating | |
|---|---|---|---|---|---|---|---|---|---|
| J&J | 234.18 | -0.15 | 564.23 | 21.68 | 10.80 | 2.50 | 251.71/146.13 | -1.67 | Bearish |
| Thermo Fisher Scientific | 526.60 | 2.05 | 200.73 | 23.02 | 22.87 | 0.30 | 643.99/385.72 | 11.36 | Bullish |
| Abbott | 96.81 | 1.40 | 167.96 | 18.80 | 5.15 | 1.92 | 139.02/93.95 | -12.53 | Very Bearish |
| Intuitive Surgical | 469.21 | 2.43 | 166.30 | 52.54 | 8.93 | -- | 603.70/427.84 | -2.80 | Neutral |
| Danaher | 194.77 | 0.51 | 140.68 | 24.97 | 7.80 | 0.56 | 242.75/180.09 | -0.05 | Neutral |
Market news
- Wall St ends mixed, notches weekly gains as investors parse Middle East negotiationsApril 11, 2026 8:53 AM
- Wall Street skids as Middle East turmoil fans inflation fearMarch 21, 2026 9:02 AM
- Wall Street closes lower, posts weekly loss as war on Iran fuels inflation worriesMarch 14, 2026 8:59 AM
- US stocks close down as oil spikes 12%, job market weakensMarch 7, 2026 9:27 AM
About the company
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.